XNAS · BFRI
+0.00% · +$0.0000 · Vol 434.0K
Market closed · last close 4:00 PM ET · price as of 16:00:00 ET
Biofrontera Inc. Common Stock

Biofrontera Inc. Common Stock

PHARMACEUTICAL PREPARATIONS
$1.14
+ Add to watchlist
Card

Veridion Score

Refresh
Score snapshot refresh in progress
Veridion Score History · 90D

Composite trend over time

HISTORY REFRESH IN PROGRESS
REFRESHES DAILY
AI Analysis
Sovereign

Why is BFRI moving today?

Sovereign unlock connects news, insider activity, analyst moves, and live price action.
Catalyst calendar
Dated receipts for BFRI are being assembled.
About Biofrontera Inc. Common Stock
PHARMACEUTICAL PREPARATIONS
Listed since
2021
Employees
94
Country
US

Biofrontera Inc is a United States-based biopharmaceutical company commercializing a portfolio of pharmaceutical products for the treatment of dermatological conditions with a focus on photodynamic therapy. The Company's licensed products, which include Ameluz as well as the BF-RhodoLED and RhodoLED XL lamps (together, the RhodoLED Lamps), are used for the treatment of actinic keratoses (AKs), which are pre-cancerous skin lesions. The company's revenues are derived from within the United States and, therefore, no other geographical segments.

Company website →
Key statistics

Reported fields plus Veridion-computed history. Unsourced tiles are omitted.

Open
$1.14
Day high
$1.20
Day low
$1.12
Previous close
$1.14
52W high
$1.20
-5.00% from high
52W low
$0.8630
82% of range
Market cap
$14.6M
EPS
$-2.4800
Shares out
12.8M
Volume
434K
VWAP
$1.15
Price history computed in-house
1W
-2.56%
1M
+26.67%
SMA 50 $1.02 · above
SMA 200 $1.02 · above
52W position 82%
Veridion warehouse edge

Warehouse intelligence for BFRI.

Veridion Score
64
0: 911: 502: 623: 204: 785: 60
Congress 30d
0
No recent disclosure on file.
Insider activity
See Form 4 panel below.
13F holders
None on file
Capital Web snapshots checked.
Disclosure-sourced lobbying and contract detail remains attributed in the full panels below.
Data ledger
Quote and day range
Refresh interval: 30 seconds
Source: Market data
Veridion Score
Coverage building
Source: Veridion methodology
Chart and risk context
Daily bars with no missing-bar fill
Source: Market data
News and filings
Refresh intervals shown inside each panel
Source: Market news and federal filings
Financials
Statements refresh in progress
SEC Form 4 ledger

BFRI insider activity

Biofrontera Inc. Common Stock

Score
Coverage building
Pressure
Mixed
Filings
0
Buys / sells
0 / 0
Net value
Not disclosed
Insiders
0
Cluster

No multi-insider buying cluster in the last 90 days

Net pressure

Mixed: Not disclosed across loaded Form 4 rows.

Convergence not established

Loaded official disclosures do not show all three sources aligned on this ticker.

Coverage building

The current Form 4 feed did not return value-bearing open-market rows for BFRI.

Source: SEC EDGAR Form 4. Rows with missing price or quantity are excluded rather than zero-filled.Methodology
Congress · 90D
Congress filing snapshot refresh in progress
Federal contracts

BFRI contract awards, year to date.

Public federal awards linked to this ticker.

Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for BFRI in this window.
Lobbying spend

BFRI lobbying filings, year to date.

Registered lobbying filings matched to Biofrontera Inc. Common Stock.

Not disclosed
Refresh interval: 12hSource: LDA disclosure filings
No lobbying filings on file for BFRI in this window.
Latest news · BFRI
Refresh interval: 5 minutes · Source: Market news insights
News snapshot refresh in progress
Analyst ratings
Sovereign unlock shows live analyst consensus for BFRI.
Options
Sovereign unlock shows live options positioning for BFRI.
Weekly Veridion brief

Rating changes, public disclosure activity, methodology notes, and product updates. One email per week. No advertising list resale.